BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22287740)

  • 41. Synthesis, DNA binding, photo-induced DNA cleavage, cytotoxicity and apoptosis studies of copper(II) complexes.
    Chen GJ; Qiao X; Qiao PQ; Xu GJ; Xu JY; Tian JL; Gu W; Liu X; Yan SP
    J Inorg Biochem; 2011 Feb; 105(2):119-26. PubMed ID: 21194609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multinuclear cytotoxic metallodrugs: physicochemical characterization and biological properties of novel heteronuclear gold-titanium complexes.
    Wenzel M; Bertrand B; Eymin MJ; Comte V; Harvey JA; Richard P; Groessl M; Zava O; Amrouche H; Harvey PD; Le Gendre P; Picquet M; Casini A
    Inorg Chem; 2011 Oct; 50(19):9472-80. PubMed ID: 21875041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxicity of a series of water-soluble mixed valent diruthenium tetracarboxylates.
    Van Rensburg CE; Kreft E; Swarts JC; Dalrymple SR; MacDonald DM; Cooke MW; Aquino MA
    Anticancer Res; 2002; 22(2A):889-92. PubMed ID: 12014667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
    Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
    Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and characterization of amino-linked heterocyclic carbene palladium, gold, and silver complexes and their use as anticancer agents that act by triggering apoptotic cell death.
    Wang CH; Shih WC; Chang HC; Kuo YY; Hung WC; Ong TG; Li WS
    J Med Chem; 2011 Jul; 54(14):5245-9. PubMed ID: 21671598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells.
    Biersack B; Dietrich A; Zoldakova M; Kalinowski B; Paschke R; Schobert R; Mueller T
    J Inorg Biochem; 2011 Dec; 105(12):1630-7. PubMed ID: 22071088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The mechanism of action of platinum anticancer agents--what do we really know about it?
    Gibson D
    Dalton Trans; 2009 Dec; (48):10681-9. PubMed ID: 20023895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
    Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
    ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
    Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
    J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, in-vitro cytotoxic activity and DNA interactions of new dicarboxylatoplatinum(II) complexes with 2-hydroxymethylbenzimidazole as carrier ligands.
    Utku S; Ozçelik AB; Gümüş F; Yılmaz S; Arsoy T; Açık L; Celebi Keskin A
    J Pharm Pharmacol; 2014 Nov; 66(11):1593-605. PubMed ID: 25109360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gold(III) compounds-mediated inhibition of lung cancer cell proliferation.
    Bostancioğlu RB; Kaya M; Koparal AT; Benkli K
    Anticancer Drugs; 2016 Mar; 27(3):225-34. PubMed ID: 26825752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
    Tan SJ; Yan YK; Lee PP; Lim KH
    Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel platinum(II) complexes of 3-(aminomethyl)naphthoquinone Mannich bases: synthesis, crystal structure and cytotoxic activities.
    Neves AP; da Silva GB; Vargas MD; Pinheiro CB; Visentin Ldo C; Filho JD; Araújo AJ; Costa-Lotufo LV; Pessoa C; de Moraes MO
    Dalton Trans; 2010 Nov; 39(42):10203-16. PubMed ID: 20871881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unexpected metal-induced isomerisms and phosphoryl migrations in Pt(II) and Pd(II) complexes of the functional phosphine 2-(bis(diphenylphosphino)methyl)-oxazoline.
    Zhang S; Pattacini R; Braunstein P
    Inorg Chem; 2011 Apr; 50(8):3511-22. PubMed ID: 21405088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics.
    Kouodom MN; Ronconi L; Celegato M; Nardon C; Marchiò L; Dou QP; Aldinucci D; Formaggio F; Fregona D
    J Med Chem; 2012 Mar; 55(5):2212-26. PubMed ID: 22309237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multifunctional O-phenanthroline silver(I) complexes for antitumor activity against colorectal adenocarcinoma cells and antimicrobial properties by multiple mechanisms.
    Niu ZL; Zhou SH; Wu YY; Wu TT; Liu QS; Zhao QH; Ji H; Ren X; Xie MJ
    J Inorg Biochem; 2023 Sep; 246():112293. PubMed ID: 37354605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.